• Financial performance: Sharda Cropchem reported a 13% year-on-year revenue increase to ₹2,065 crore and a 57% surge in net profit to ₹319 crore for the quarter, closing the full year with record sales of ₹5,268 crore and net profit of ₹681 crore.
• Growth outlook: Management conservatively projects 10% to 15% growth in both revenue and net profit for the current financial year, with the non-agro segment expected to grow by 15% to 20%.
• Capex on registrations: The company plans a capex of ₹500 crore to ₹550 crore focused on product registrations, which will be entirely funded through internal cash flows under its asset-light, zero-debt model.
• Tariff resilience: US tariffs on products sourced from Chinese partners do not hurt margins, as registration barriers allow the company to pass increased costs directly on to buyers.
• Operational strategy: The company operates without owned manufacturing plants, sourcing from suppliers at 10% to 15% of their capacity, and has ruled out near-term acquisitions to focus on organic product registrations.